参考文献/References:
[1]王曼虹.冠心病合并糖尿病患者冠状动脉病变特点研究[D].杭州:浙江大学,2003.[2]Li R,Shi T,Xing E,et al.Atorvastatin calcium tablets on inflammatory factors, hemorheology and renal function damage indexes in patients with diabetic nephropathy[J].Pak J Med Sci,2021,37(5):1392-1396. [3]Catapano AL,Graham I,De Backer G,et al.2016 ESC/EAS guidelines for the management of dyslipidaemias[J].Rev Esp Cardiol (Engl Ed),2017,70(2):115.[4]余显霞,曹蕾,熊雪松.阿司匹林肠溶片联合阿托伐他汀钙片对糖尿病动脉粥样硬化的干预治疗研究[J].川北医学院学报,2017,32(3):358-360．[5]余科,张志新,韩玉乐,等.不同剂量阿托伐他汀对急性脑梗死合并大脑中动脉狭窄患者预后的影响[J].中风与神经疾病杂志,2017,34(3):268-270.[6]樊维娜,王建新,孙经武.不同剂量阿托伐他汀钙在亚洲人急性心肌梗死治疗中应用疗效观察[J].陕西医学杂志,2016,45(1):93-95.[7]耿娜,祁辉,刘静芹.瑞舒伐他汀治疗男性初诊2型糖尿病伴高脂血症的疗效及对血清vaspin水平的影响[J].河北医药,2016,38(18):2775-2777.[8]赵丽娜,马国库,高亚楠,等.阿司匹林联合阿托伐他汀治疗糖尿病并发动脉粥样硬化对血糖、血脂和氧化应激的影响[J].疑难病杂志,2018,17(4):357-361.[9]Zhang N,Hu X,Zhang Q,et al.Non-high-density lipoprotein cholesterol: High-density lipoprotein cholesterol ratio is an inde- pendent risk factor for diabetes mellitus: Results from a population-based cohort study[J].J Diabetes,2018,10(9):708-714．[10]任丽君,张麦叶,高彬.阿托伐他汀对2型糖尿病患者单核细胞toll样受体4表达和炎症因子的影响[J].安徽医药,2018,22(8):1558-1561.[11]郑舒,沃金善,赵青,等.阿托伐他汀和罗格列酮对2型糖尿病并不稳定型心绞痛病人炎症因子的影响[J].青岛大学医学院学报,2009,45(3):274-276.[12]胡义奎,叶恒泰,沈伟,等.阿托伐他汀对高血糖状态下脑缺血血管新生的影响[J].中华全科医学,2016,14(9):1466-1469.[13]杨培根,单瑞,程爱娟,等.他汀类药物治疗对2型糖尿病并ST段抬高急性心肌梗死患者磷脂酶A2和心功能的影响[J].中华老年医学杂志,2015,34(8):854-857.[14]伍媛,刘翠中,邹燕.瑞舒伐他汀对糖尿病大鼠心肌功能和NT-pro-BNP的影响[J].湖南师范大学学报(医学版),2017,14(2):69-71.[15]段海霞,王班伟,段素静,等.他汀类药物治疗高血脂非增生型糖尿病视网膜病变的效果观察[J].广东医学院学报,2016,34(2):214-217.[16]黄国政,雷梅花,翁军华,等.瑞舒伐他汀联合依帕司他治疗2型糖尿病早期视网膜病变临床疗效及对D-二聚体、Hcy、VEGF、NES和IGF-1水平影响[J].浙江中西医结合杂志,2020,30(2):130-132.[17]Faselis C,Katsimardou A,Imprialos K,et al.Microvascular Complications of Type 2 Diabetes Mellitus[J].Curr Vasc Pharmacol,2020,18(2):117-124.[18]王玉肖,李娟娟,赵灿,等.阿托伐他汀钙片对糖尿病肾病患者炎性因子、微循环障碍和血小板参数的影响[J].临床误诊误治,2020,33(9):34-38.[19]张蓓慧.瑞舒伐他汀对早期糖尿病肾病患者外周血内血清瘦素、炎性因子、血脂水平及肾功能的影响[J].中国药物警戒,2017,14(6):338-340,352.[20]刘英,周英,杨海燕,等.不同剂量阿托伐他汀对老年早期糖尿病肾病患者NF-κB、炎性因子及胰岛素抵抗的影响研究[J].海南医学院学报,2016,22(1):45-47,50.[21]杨强,赵燕俐,刘俊保.替米沙坦联合阿托伐他汀治疗早期糖尿病肾病的效果[J].河南医学研究,2019,28(17):3080-3083.[22]王晓光,谭婷婷,任迪.补脾益肾活血法对糖尿病肾病患者氧化应激水平及炎症因子的影响[J].中国中西医结合肾病杂志,2015(12):1063-1067.[23]张蓓慧.瑞舒伐他汀对早期糖尿病肾病患者外周血内血清瘦素、炎性因子、血脂水平及肾功能的影响[J].中国药物警戒,2017,14(6):338-340,352. [24]黄林晶,杨立勇,沈喜妹,等.游离脂肪酸对胰岛素瘤细胞系βTc6细胞葡萄糖激酶和葡萄糖转运蛋白2表达及胰岛素分泌功能的影响[J].中华糖尿病杂志,2011,3(3):247-251.[25]Moussavi K,Fitter S,Gabrielson SW,et al.Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician[J].J Emerg Med,2019,57(1):36-42.[26]Edgerton DS,Kraft G,Smith M,et al.Insulin’s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion[J].JCI Insight,2017,2(6):e91863.[27]Wang J,Wang Z,Yu J,et al.Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation[J].Adv Mater,2020,32(13):e1902004.[28]Nishikido T,Oyama J,Keida T,et al.High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA- LDL:the standard versus high-dose therapy with rosuvastatin for lipid lowering (SARD)trial[J].J Cardiol,2016,67:340-346.[29]唐丹,张剑彬,陈莉,等.前列地尔对2型糖尿病肾病患者氧化应激损伤的影响[J].重庆医学,2018,47(17):2369-2371. [30]王丽,赵勇,陈娟,周洁,等.血清瘦素水平与冠状动脉病变程度的关系[J].临床心血管病杂志,2006,22(12):719-720.[31]李庚,吴巧稚,顾刘宝.2型糖尿病病人他汀类药物使用单中心横断面分析[J].安徽医药,2017,22(6):139-144.[32]Fu J,Yang J,Seeberger PH,et al.Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment[J].Carbohydr Res,2020,498:108195.[33]Stanirowski PJ,Szukiewicz D,Pazura-Turowska M,et al.Placental Expression of Glucose Transporter Proteins in Pregnancies Complicated by Gestational and Pregestational Diabetes Mellitus[J].Can J Diabetes,2018,42(2):209-217.[34]Deng D,Yan N.GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters[J].Protein Sci,2016,25(3):546-558.[35]刘建青,乔晋,王宏.阿托伐他汀、辛伐他汀和瑞舒伐他汀对高脂血症的疗效比较[J].药物评价研究,2017,40(10):1457-1459.[36]Ren Y,Zhu H,Fan Z,et al.Comparison of the effect of rosuvastatin versus rosuvastatin/ ezetimibe on markers of inflammation in patients with acute myocardial infarction[J].Exp Ther Med,2017,14:4942-4950.[37]徐洪伟.瑞舒伐他汀钙联合依折麦布对降脂未达标的2型糖尿病患者的疗效分析[J].北京医学,2019,41(10):938-940.[38]Dehnavi S,Kiani A,Sadeghi M,et al.Targeting AMPK by Statins: A Potential Therapeutic Approach[J].Drugs,2021,81(8):923-933.[39]Jones S,Fernandes NV,Yeganehjoo H,et al.β-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells[J].Nutr Cancer,2013,65(4):600-610.[40]Lim WJ,Lee M,Oh Y,et al.Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling[J].Cells,2021,10(9):2488.
相似文献/References:
[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal
Cancer[J].Journal of Medical Information,2018,31(17):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign
Tumor and Diabetic Patients[J].Journal of Medical Information,2018,31(17):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2018,31(17):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Journal of Medical Information,2018,31(17):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[7]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Journal of Medical Information,2018,31(17):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[8]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的
临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(17):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[9]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[10]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]